{"id":37231,"date":"2026-07-02T21:14:18","date_gmt":"2026-07-02T21:14:18","guid":{"rendered":"https:\/\/blogemergencias.es\/index.php\/2026\/07\/02\/los-hospitales-y-las-farmacias-duplican-el-consumo-de-medicamentos-biosimilares-en-cinco-anos\/"},"modified":"2026-07-02T21:14:18","modified_gmt":"2026-07-02T21:14:18","slug":"los-hospitales-y-las-farmacias-duplican-el-consumo-de-medicamentos-biosimilares-en-cinco-anos","status":"publish","type":"post","link":"https:\/\/blogemergencias.es\/index.php\/2026\/07\/02\/los-hospitales-y-las-farmacias-duplican-el-consumo-de-medicamentos-biosimilares-en-cinco-anos\/","title":{"rendered":"Los hospitales y las farmacias duplican el consumo de medicamentos biosimilares en cinco a\u00f1os"},"content":{"rendered":"<div data-nosnippet=\"\" data-id=\"closeContentContainer\"><!--[--><!--[--><!----><!----><!--[--><\/p>\n<p class=\"ft-text ft-helper-closenews\">El uso de <a class=\"ft-link ft-link--decoration broken_link\" href=\"\/es\/temas\/medicamentos-18611\">medicamentos<\/a> <strong>biosimilares<\/strong> ha experimentado una \u00abexpansi\u00f3n notable\u00bb en todo el Sistema Nacional de Salud. As\u00ed lo subraya el<a class=\"ft-link ft-link--decoration broken_link\" href=\"\/es\/temas\/ministerio-sanidad-43404\"> Ministerio de Sanidad<\/a>, que ha publicado el informe &#8216;Adopci\u00f3n de <strong>medicamentos gen\u00e9ricos, h\u00edbridos y biosimilares<\/strong> en el Sistema Nacional de Salud&#8217;, un estudio del periodo 2020-2025 que posiciona a estos f\u00e1rmacos<strong> como \u00abpiezas clave\u00bb<\/strong> para la sostenibilidad del sistema p\u00fablico. <a class=\"ft-link ft-link--decoration broken_link\" href=\"\/es\/sociedad\/20251124\/uab-impulsa-empresa-medicamentos-biosimilares-124057751\">El volumen de biosimilares<\/a> en hospitales pas\u00f3 de 2,4 a 4,9 millones de envases entre 2020 y 2025, mientras que en farmacias creci\u00f3 <strong>de 1,3 a 2,7 millones.<\/strong><\/p>\n<p><!--]--><!----><!----><!----><!----><!----><!----><!----><!----><!----><\/p>\n<aside class=\"ft-ad ft-ad--roba ft-ad--robaNotext ft-helper-hide-md\" style=\"\"\/><!--[--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--]--><!----><!----><!--]--><!--[--><!----><!----><!--[--><\/p>\n<p class=\"ft-text\"><strong>Un medicamento biol\u00f3gico similar<\/strong> (com\u00fanmente denominado medicamento biosimilar) es un f\u00e1rmaco equivalente <strong>en su estructura molecular,<\/strong> actividad farmacol\u00f3gica, eficacia y seguridad a otro biol\u00f3gico, denominado <strong>medicamento de referencia<\/strong>, autorizado en el espacio econ\u00f3mico europeo (EEE), cuya patente ha vencido y del que existe una amplia experiencia de uso cl\u00ednico.<\/p>\n<p><!--]--><!----><!----><!----><!----><!----><!--[--><!----><!----><!--]--><!----><!----><!----><!----><!----><!--[--><!--[--><\/p>\n<aside class=\"ft-ad ft-ad--intext ft-helper-hide-md\"\/><!--]--><!--[--><\/p>\n<aside class=\"ft-ad ft-ad--intext  ft-helper-hide-xs\"\/><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--]--><!----><!----><!--]--><!--[--><!----><!----><!----><!----><!----><!----><\/p>\n<h3 class=\"ft-helper-spacer-t-xs ft-helper-fontSize-heading-XS\">Oncolog\u00eda<\/h3>\n<p><!----><!----><!----><!----><!----><!----><!----><!--[--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--]--><!----><!----><!--]--><!--[--><!----><!----><!--[--><\/p>\n<p class=\"ft-text\">Con datos del informe de Sanidad, <strong>en el \u00e1mbito hospitalario<\/strong>, el n\u00famero de mol\u00e9culas con biosimilar disponible creci\u00f3 de 14 a 22 en cinco a\u00f1os. Actualmente, estos f\u00e1rmacos representan <strong>el 81,5%<\/strong> de los <a class=\"ft-link ft-link--decoration broken_link\" href=\"\/es\/sanidad\/20260702\/agencia-europea-medicamentos-recomienda-retirada-avacopan-farmaco-enfermedades-raras-dano-hepatico-132036834\">envases en mercados competitivos<\/a>, habi\u00e9ndose incrementado el n\u00famero de envases consumidos de 2,4 a 4,9 millones en cinco a\u00f1os.<\/p>\n<p><!--]--><!----><!----><!----><!----><!----><!----><!----><!----><!----><!----><!--[--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--]--><!----><!----><!--]--><!--[--><!----><!----><!--[--><\/p>\n<p class=\"ft-text\">Sanidad destaca el comportamiento <strong>en Oncolog\u00eda<\/strong>, donde los biosimilares de mol\u00e9culas como<strong> bevacizumab o eculizumab<\/strong> superan el 90% de cuota de mercado en menos de tres a\u00f1os desde la salida al mercado del primer biosimilar.<\/p>\n<p><!--]--><!----><!----><!----><!----><!----><!----><!----><!----><!----><!----><\/p>\n<aside class=\"ft-ad ft-ad--roba ft-ad--robaNotext ft-helper-hide-md\" style=\"\"\/><!--[--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--]--><!----><!----><!--]--><!--[--><!----><!----><!----><!----><!----><!----><\/p>\n<h2 class=\"ft-helper-spacer-t-xs ft-helper-fontSize-heading-S\">En las farmacias<\/h2>\n<p><!----><!----><!----><!----><!----><!----><!----><!--[--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--]--><!----><!----><!--]--><!--[--><!----><!----><!--[--><\/p>\n<p class=\"ft-text\"><strong>En las oficinas de <\/strong><a class=\"ft-link ft-link--decoration broken_link\" href=\"\/es\/temas\/farmacias-18613\">farmacia<\/a>, aunque el cat\u00e1logo es m\u00e1s reducido, el volumen tambi\u00e9n <strong>se duplic\u00f3 hasta los 2,7 millones de envases<\/strong>. El informe se\u00f1ala que, a pesar de la ausencia de sustituci\u00f3n autom\u00e1tica en este canal, el biosimilar sigue ganando terreno \u00abde forma gradual y sostenida\u00bb.<\/p>\n<p><!--]--><!----><!----><!----><!----><!----><!----><!----><!----><!----><!----><!----><!--[--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--]--><!----><!----><!--]--><!--[--><!----><!----><!--[--><\/p>\n<p class=\"ft-text\"><strong>Los medicamentos gen\u00e9ricos e h\u00edbridos<\/strong>\u00a0siguen siendo la base cuantitativa del ahorro del gasto farmac\u00e9utico, se apunta. En los hospitales, su penetraci\u00f3n en importe alcanza el 69,5%, impulsada por la r\u00e1pida adopci\u00f3n de f\u00e1rmacos de alto impacto <strong>como la lenalidomida o la abiraterona<\/strong>. El volumen de envases en el \u00e1mbito hospitalario aumento de 19,8 millones<strong> a 31,4 millones entre 2020-2025.<\/strong><\/p>\n<p><!--]--><!----><!----><!----><!----><!----><!----><!----><!----><!----><!----><!----><!--[--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><\/p>\n<aside class=\"ft-ad ft-ad--intext ft-helper-hide-md\"\/><!--]--><!--[--><\/p>\n<aside class=\"ft-ad ft-ad--intext  ft-helper-hide-xs\"\/><!--]--><!--]--><!----><!----><!--]--><!--[--><!----><!----><!----><!----><!----><!----><\/p>\n<h3 class=\"ft-helper-spacer-t-xs ft-helper-fontSize-heading-XS\">Suministro<\/h3>\n<p><!----><!----><!----><!----><!----><!----><!----><!--[--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--]--><!----><!----><!--]--><!--[--><!----><!----><!--[--><\/p>\n<p class=\"ft-text\">Por su parte, <a class=\"ft-link ft-link--decoration broken_link\" href=\"\/es\/videos\/sociedad\/sanidad-ofrecera-preservativos-gratuitos-farmacias\/131172330.shtml\">en las farmacias<\/a> se dispensaron 602,2 millones de envases de gen\u00e9ricos e h\u00edbridos en 2025, manteniendo una cuota estable del 59,8%. El informe destaca que el 90% de este incremento en farmacias <strong>proviene de mol\u00e9culas ya consolidadas<\/strong>, lo que demuestra \u00abla madurez\u00bb de estos mercados.<\/p>\n<p><!--]--><!----><!----><!----><!----><!----><!--[--><!----><!----><!--]--><!----><!----><!----><!----><!--[--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--]--><!----><!----><!--]--><!--[--><!----><!----><!--[--><\/p>\n<p class=\"ft-text\">M\u00e1s all\u00e1 del ahorro econ\u00f3mico, Sanidad destaca que disponer de una red diversificada de fabricantes de gen\u00e9ricos y biosimilares \u00abrefuerza la resiliencia del suministro farmac\u00e9utico\u00bb ante posibles interrupciones en <strong>las cadenas globales.<\/strong><\/p>\n<p><!--]--><!----><!----><!----><!----><!----><!----><!----><!----><!----><!----><!----><!--[--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--[--><!----><!--]--><!--]--><!----><!----><!--]--><!--]--><\/p>\n<p data-close=\"closedContent\" class=\"subscribeHideForDisplay\">Suscr\u00edbete para seguir leyendo<\/p>\n<\/div>\n<p><a href=\"https:\/\/www.elperiodico.com\/es\/sanidad\/20260702\/hospitales-farmacias-duplican-consumo-medicamentos-biosimilares-132047695?utm_source=rss-noticias&amp;utm_medium=feed&amp;utm_campaign=sanidad\" class=\"broken_link\">source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El uso de medicamentos biosimilares ha experimentado una \u00abexpansi\u00f3n notable\u00bb en todo el Sistema Nacional de Salud. As\u00ed<\/p>\n","protected":false},"author":1,"featured_media":37232,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"_joinchat":[],"footnotes":""},"categories":[1],"tags":[],"class_list":["post-37231","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"featured_image_urls":{"full":["https:\/\/blogemergencias.es\/wp-content\/uploads\/2026\/07\/wp-header-logo-77.png",1200,675,false],"thumbnail":["https:\/\/blogemergencias.es\/wp-content\/uploads\/2026\/07\/wp-header-logo-77-150x150.png",150,150,true],"medium":["https:\/\/blogemergencias.es\/wp-content\/uploads\/2026\/07\/wp-header-logo-77-300x169.png",300,169,true],"medium_large":["https:\/\/blogemergencias.es\/wp-content\/uploads\/2026\/07\/wp-header-logo-77-768x432.png",640,360,true],"large":["https:\/\/blogemergencias.es\/wp-content\/uploads\/2026\/07\/wp-header-logo-77-1024x576.png",640,360,true],"1536x1536":["https:\/\/blogemergencias.es\/wp-content\/uploads\/2026\/07\/wp-header-logo-77.png",1200,675,false],"2048x2048":["https:\/\/blogemergencias.es\/wp-content\/uploads\/2026\/07\/wp-header-logo-77.png",1200,675,false],"morenews-large":["https:\/\/blogemergencias.es\/wp-content\/uploads\/2026\/07\/wp-header-logo-77-825x575.png",825,575,true],"morenews-medium":["https:\/\/blogemergencias.es\/wp-content\/uploads\/2026\/07\/wp-header-logo-77-590x410.png",590,410,true]},"author_info":{"info":["admin"]},"category_info":"<a href=\"https:\/\/blogemergencias.es\/index.php\/category\/noticias\/\" rel=\"category tag\">Noticias<\/a>","tag_info":"Noticias","comment_count":0,"_links":{"self":[{"href":"https:\/\/blogemergencias.es\/index.php\/wp-json\/wp\/v2\/posts\/37231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogemergencias.es\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogemergencias.es\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogemergencias.es\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blogemergencias.es\/index.php\/wp-json\/wp\/v2\/comments?post=37231"}],"version-history":[{"count":0,"href":"https:\/\/blogemergencias.es\/index.php\/wp-json\/wp\/v2\/posts\/37231\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogemergencias.es\/index.php\/wp-json\/wp\/v2\/media\/37232"}],"wp:attachment":[{"href":"https:\/\/blogemergencias.es\/index.php\/wp-json\/wp\/v2\/media?parent=37231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogemergencias.es\/index.php\/wp-json\/wp\/v2\/categories?post=37231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogemergencias.es\/index.php\/wp-json\/wp\/v2\/tags?post=37231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}